Bladder Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Bladder Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors [Phase 1]
Phase 1 trial evaluating cabozantinib S-malate with nivolumab, with or without ipilimumab, in patients with metastatic genitourinary tumors;…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer [Phase 2]
A Phase 2 trial evaluating radiation therapy with cemiplimab, with or without fianlimab, in bladder urothelial carcinoma. The study status i…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial [Phase 2]
Phase 2 INSPIRE trial evaluating whether adding durvalumab to chemotherapy and radiation improves outcomes in bladder urothelial carcinoma w…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL) [Phase 3]
NAUTICAL is a Phase 3 neoadjuvant trial for upper tract invasive cancer, currently recruiting; the listed conditions include bladder cancer …
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 trial exploring bladder-preserving therapy with sacituzumab govitecan plus zimberelimab for muscle-invasive bladder cancer; the stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.